NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) | PAR 19 032

Opportunity Information: Apply for PAR 19 032

The funding opportunity titled "NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)" (Funding Opportunity Number PAR 19 032) is a discretionary grant program run by the U.S. Department of Health and Human Services through the National Institutes of Health (NIH), specifically the National Library of Medicine (NLM). Its core purpose is to support the development of substantial scholarly products, most notably book-length manuscripts, as well as other major written works that have clear academic value and/or relevance to public health policy. The intended audience for the finished work is broad but professionally focused, including U.S. health professionals, public health officials, biomedical researchers, and historians of the health sciences. In practical terms, this program is aimed at helping authors complete rigorous, high-impact writing projects that synthesize knowledge, interpret evidence, or document important historical and scientific developments in ways that serve the health and biomedical community.

This opportunity uses the grant funding instrument and falls under the Education and Health funding activity category, with CFDA number 93.879. A key limitation is stated directly in the title: clinical trials are not allowed under this mechanism, which signals that the grant is intended for scholarship and authorship rather than for conducting prospective human subject intervention studies. The support is therefore geared toward the research, analysis, organization, and writing needed to produce a major scholarly work, rather than supporting experimental or clinical study execution.

Eligibility is notably expansive and includes many types of organizations. Eligible applicants include state, county, city or township governments, special district governments, and independent school districts. Higher education institutions are eligible across multiple categories, including public and state-controlled institutions of higher education as well as private institutions of higher education. The opportunity is also open to federally recognized Native American tribal governments and other Native American tribal organizations, along with public housing authorities/Indian housing authorities. Nonprofits are eligible whether or not they hold 501(c)(3) status, as long as they are not institutions of higher education in those categories, and for-profit organizations are also eligible, including small businesses and other for-profit entities outside the small business category. The listing also includes an "Others" category, indicating that additional applicant types may qualify depending on the specific clarifications provided in the program materials.

In terms of funding size and scale, the award ceiling is listed as $50,000, and the program anticipated making around three awards. This suggests a relatively selective program with modest individual award sizes, designed to provide targeted support that can make the difference in completing a complex manuscript or comparable scholarly product. The emphasis is on the preparation of a finished, usable work rather than on building large research infrastructure or supporting wide-scale program operations.

The opportunity record shows a creation date of October 23, 2018, with an original closing date of February 26, 2020. While these dates indicate the specific posting and deadline information for that iteration, the underlying program concept is centered on advancing high-quality scholarly communication in biomedicine and health and promoting works that can inform professional practice, public health decision-making, biomedical research understanding, and historical scholarship in the health sciences.

• The Department of Health and Human Services, National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.879.
• This funding opportunity was created on Oct 23, 2018.
• Applicants must submit their applications by Feb 26, 2020. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $50,000.00 in funding.
• The number of recipients for this funding is limited to 3 candidate(s).
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for PAR 19 032

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: